JP2017512202A5 - - Google Patents

Download PDF

Info

Publication number
JP2017512202A5
JP2017512202A5 JP2016554261A JP2016554261A JP2017512202A5 JP 2017512202 A5 JP2017512202 A5 JP 2017512202A5 JP 2016554261 A JP2016554261 A JP 2016554261A JP 2016554261 A JP2016554261 A JP 2016554261A JP 2017512202 A5 JP2017512202 A5 JP 2017512202A5
Authority
JP
Japan
Prior art keywords
composition
sequence
cholesterol
nucleic acid
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016554261A
Other languages
English (en)
Japanese (ja)
Other versions
JP6772065B2 (ja
JP2017512202A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/054131 external-priority patent/WO2015128461A1/en
Publication of JP2017512202A publication Critical patent/JP2017512202A/ja
Publication of JP2017512202A5 publication Critical patent/JP2017512202A5/ja
Application granted granted Critical
Publication of JP6772065B2 publication Critical patent/JP6772065B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016554261A 2014-02-28 2015-02-27 免疫賦活プラスミド Expired - Fee Related JP6772065B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461946372P 2014-02-28 2014-02-28
US61/946,372 2014-02-28
PCT/EP2015/054131 WO2015128461A1 (en) 2014-02-28 2015-02-27 Immunostimulatory plasmids

Publications (3)

Publication Number Publication Date
JP2017512202A JP2017512202A (ja) 2017-05-18
JP2017512202A5 true JP2017512202A5 (enExample) 2018-04-05
JP6772065B2 JP6772065B2 (ja) 2020-10-21

Family

ID=52598746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016554261A Expired - Fee Related JP6772065B2 (ja) 2014-02-28 2015-02-27 免疫賦活プラスミド

Country Status (20)

Country Link
US (2) US10155950B2 (enExample)
EP (1) EP3110940A1 (enExample)
JP (1) JP6772065B2 (enExample)
KR (1) KR20160122849A (enExample)
CN (1) CN106029867B (enExample)
AU (1) AU2015222102B2 (enExample)
BR (1) BR112016019837A2 (enExample)
CA (1) CA2940794C (enExample)
CL (1) CL2016002146A1 (enExample)
CR (1) CR20160393A (enExample)
DO (1) DOP2016000223A (enExample)
IL (1) IL247065A0 (enExample)
MX (1) MX2016010993A (enExample)
PE (1) PE20170404A1 (enExample)
PH (1) PH12016501705A1 (enExample)
RU (1) RU2740492C2 (enExample)
SV (1) SV2016005263A (enExample)
UA (1) UA118374C2 (enExample)
WO (1) WO2015128461A1 (enExample)
ZA (1) ZA201605495B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3110940A1 (en) * 2014-02-28 2017-01-04 Bayer Animal Health GmbH Immunostimulatory plasmids
EP3164113B1 (en) 2014-06-04 2019-03-27 Exicure, Inc. Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
US11213593B2 (en) 2014-11-21 2022-01-04 Northwestern University Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
US20190233825A1 (en) * 2015-06-26 2019-08-01 Bayer Animal Health Gmbh Methods of modulating cytosolic dna surveillance molecules
CN108712912B (zh) * 2015-07-31 2022-05-10 拜耳动物保健有限责任公司 在水生物种中增强的免疫应答
TW201718001A (zh) * 2015-07-31 2017-06-01 拜耳動物保健有限公司 豬物種中增強之免疫反應
EP3490598A1 (en) * 2016-07-26 2019-06-05 Bayer Animal Health GmbH Increased fertility in bovine species
US11364304B2 (en) 2016-08-25 2022-06-21 Northwestern University Crosslinked micellar spherical nucleic acids
WO2018209270A1 (en) 2017-05-11 2018-11-15 Northwestern University Adoptive cell therapy using spherical nucleic acids (snas)
CN111801419A (zh) * 2017-12-15 2020-10-20 拜耳动物保健有限责任公司 免疫刺激性寡核苷酸
CN109646435B (zh) * 2019-01-11 2021-08-03 山东省农业科学院奶牛研究中心 厄他培南钠在制备防治牛传染性鼻气管炎药物中的应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5427791A (en) 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6645933B1 (en) * 1995-08-01 2003-11-11 Helsinki University Licensing Ltd. Oy Receptor ligand VEGF-C
US5830878A (en) 1995-06-07 1998-11-03 Megabios Corporation Cationic lipid: DNA complexes for gene targeting
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US6048535A (en) 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
US20040247662A1 (en) 1998-06-25 2004-12-09 Dow Steven W. Systemic immune activation method using nucleic acid-lipid complexes
US6693086B1 (en) 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
US20030022854A1 (en) 1998-06-25 2003-01-30 Dow Steven W. Vaccines using nucleic acid-lipid complexes
EP1955709B1 (en) 1999-03-26 2012-03-14 Vical Incorporated Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines
US20040002472A1 (en) 2000-01-21 2004-01-01 Audonnet Jean-Christophe Francis Vaccination or immunization using a prime-boost regimen
US6517218B2 (en) 2000-03-31 2003-02-11 Relume Corporation LED integrated heat sink
JP4261195B2 (ja) * 2001-04-24 2009-04-30 イノジェネティックス・ナムローゼ・フェンノートシャップ 酵母のコア−グリコシル化されたｈｃｖエンベロープタンパク質の発現
WO2003004051A2 (en) 2001-07-02 2003-01-16 Pfizer Products Inc. Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
AU2002953015A0 (en) * 2002-12-02 2002-12-12 Women's And Children's Hospital Modified lacz gene
NZ542652A (en) 2003-03-26 2008-04-30 Wyeth Corp Immunogenic composition and methods
JP2007509040A (ja) 2003-10-11 2007-04-12 イネックス ファーマシューティカルズ コーポレイション 先天性免疫及び抗体依存性細胞傷害を強化するための方法及び組成物
US20050181035A1 (en) 2004-02-17 2005-08-18 Dow Steven W. Systemic immune activation method using non CpG nucleic acids
AU2005271247A1 (en) 2004-08-13 2006-02-16 The Trustees Of The University Of Pennsylvania Antibiotic resistance free DNA vaccines
UY29915A1 (es) 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
TWM297441U (en) 2006-03-30 2006-09-11 Cheng-Jiun Jian LED projection light source module
US7663229B2 (en) 2006-07-12 2010-02-16 Hong Kong Applied Science And Technology Research Institute Co., Ltd. Lighting device
EP2069378B1 (en) * 2006-10-06 2016-10-05 The Scripps Research Institute Dna composition for eliciting an immune response against tumor-associated macrophages
US8470560B2 (en) * 2007-10-03 2013-06-25 The United States Of America As Represented By The Secretary Of The Army CR-2 binding peptide P28 as molecular adjuvant for DNA vaccines
CA2719614C (en) 2008-03-25 2018-05-01 Juvaris Biotherapeutics, Inc. Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
EP2362780B1 (en) 2008-10-31 2019-12-25 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
SI2992899T1 (sl) * 2009-05-14 2020-10-30 Bayer Intellectual Property Gmbh Povečan imunski odziv pri ptičjih vrstah
DK2654785T3 (da) 2010-12-22 2019-06-24 Bayer Ip Gmbh Forøget immunrespons hos kvægracer
CL2011000065A1 (es) 2011-01-11 2011-04-15 Univ Concepcion Formulacion veterinaria para la prevencion y eliminacion de infeccion por cepas de e. coli stec, que comprende un plasmido recombinante que codifica un factor de virulencia y liposoma cationico como vehiculo, uso de dicha formulacion para tratar preferentemente bovinos y porcinos.
EP3110940A1 (en) * 2014-02-28 2017-01-04 Bayer Animal Health GmbH Immunostimulatory plasmids

Similar Documents

Publication Publication Date Title
RU2016138321A (ru) Иммуностимулирующие плазмиды
JP7523897B2 (ja) 呼吸器合胞体ウイルス（ｒｓｖ）ワクチン
Schwendener Liposomes as vaccine delivery systems: a review of the recent advances
JP7817257B2 (ja) ｍＲＮＡワクチンを送達するための脂質ナノ粒子
JP4294584B2 (ja) 核酸ワクチン接種の免疫応答を高めるための方法
RU2013133730A (ru) Повышение иммунного отклика у видов крупного рогатого скота
JP2014522842A5 (enExample)
JP2014520807A5 (enExample)
CN101616687B (zh) 非特异性免疫刺激剂
EP4153224A1 (en) Coronavirus antigen compositions and their uses
EP4091630A1 (en) Vaccines comprising r-dotap
MXPA05013746A (es) Conjugados de esfingoide-polialquilamina para vacunacion.
US20190125858A1 (en) Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery
RU2014135522A (ru) Промоторы для увеличенной экспрессии белка у менингококка
JP2018518511A5 (enExample)
US11111277B2 (en) Influenza vaccines
Lee et al. Perspective of peptide vaccine composed of epitope peptide, CpG-DNA, and liposome complex without carriers
AR105568A1 (es) Un método para provocar una respuesta inmunitaria en un sujeto receptor de especie porcina
US20250281588A1 (en) Prevention and treatment of infections with intracellular bacteria
Tomai et al. TLR agonists as vaccine adjuvants
EP3035960A2 (en) Respiratory syncytial virus (rsv) vaccine
US20240316178A1 (en) Recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap and methods of use thereof
EP3328423B1 (en) Enhanced immune response in fish
HK40083470A (en) Vaccines comprising r-dotap
RU2015140822A (ru) Рекомбинантная противогриппозная вакцина с широким спектром защиты и способ ее получения